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A B S T R A C T
The aim of the study was to investigate the effects of chorioamnionitis on mortality and early onset neonatal sepsis
(EONS) and bronchopulmonary dysplasia (BPD) in preterm neonates with birth weight £1,500 g. The study included
395 preterm infants born at the Zagreb Clinical Hospital Center, from January 2001 to December 2005. All the placentas
from preterm deliveries were sent for pathological examination. The patients were categorized into two groups: one in-
cluding patients with chorioamnionitis at placental histology (47%) and the other control group without chorioamnio-
nitis (53%). Neonates were distributed into 3 groups according to gestational age: the first group with 132 (33%) infants
born at £28 weeks of gestation, the second with 202 (52%) infant born from 29 to 32 weeks of gestation and the third with
61 (15%) infants born at ³33 weeks gestation. Chorioamnionitis was diagnosed significantly more often in the first gesta-
tional age group (91/132-69% of infants, c2=51.307, p<0.05). The outcome was lethal in 67/395 (17%) patients; 55% of
them had chorioamnionitis (c2=2.421, p>0.05). Lethal outcome ensued in 54/132 (41%) infants from the first gesta-
tional age group; 30/54 (55%) were born from pregnancies complicated by chorioamnionitis. In comparison with the con-
trol group, mortality was significantly higher in the group of premature infants with gestation £28 weeks whose placen-
tas showed chorioamnionitis (c2=7.645, p<0.01). EONS was probable or confirmed in 100/395 (25%) infants; in 66/100
(66%) infants pregnancy was complicated by chorioamnionitis (c2=22.396, p<0.01). BPD developed in 25/395 (6%) in-
fants; in 12/25 (48%) infants placentas showed chorioamnionitis (c2=0.022, p>0.05). In conclusion, premature neonates
from pregnancies complicated by chorioamnionitis are more often born at £28 weeks of gestation. Chorioamnionitis in
neonates whose gestation is £28 weeks leads to a significantly higher rate of mortality than in neonates with a longer ges-
tation period. A greater incidence of EONS was proven in the group of infants with chorioamnionitis. The difference be-
tween the incidence of BPD in preterm infants born from pregnancies complicated by chorioamnionitis and the control
group was not significant.
Key words: chorioamnionitis, early onset neonatal sepsis, bronchopulmonary dysplasia
Introduction
Chorioamnionitis is an inflammation of the mem-
branes and chorion of the placenta1. It is clinically evi-
dent in 1–10% pregnancies, while in the most cases the
pregnancies up to its manifestation are asymptomatic2.
Chorioamnionitis is etiologically associated with preterm
labour and can be found in 40% of preterm deliveries3.
Despite great advances in perinatology during the last 20
years, the incidence of preterm labour is still as high as
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10% or even greater. One to two percent of deliveries re-
sult in the birth of neonates weighting<1,500 grams3,4.
The results of studies about the effect of chorioamnio-
nitis on neonatal outcomes are still controversial but
many of them point toward higher neonatal mortality
and morbidity rates in neonates born from pregnancies
with chorioamnionitis2. The presence of inflammatory
mediators, primarily cytokines in the amniotic fluid and
fetal blood associated with chorioamnionitis is an impor-
tant factor causing the rupture of fetal membranes, thus
inducing preterm delivery5. The high level of proinflam-
matory cytokines in fetal blood is associated with higher
rates of neonatal mortality and morbidity2,6.
The aim of this study was to analyse the association
between histopathologically confirmed chorioamnionitis
on the one hand and mortality and morbidity rates in
preterm neonates with birth weight £1,500 grams on the
other. The analysis of morbidity included cases of early
onset neonatal sepsis (EONS) and bronchopulmonary
dysplasia (BPD).
Patients/Material and Methods
All preterm neonates with birth weight £1,500 grams
that were admitted to the Neonatal Intensive Care Unit
of the Department of Obstetrics and Gynecology, Zagreb
Clinical Hospital Center, from January 2001 to Decem-
ber 2005, were included in this retrospective study. Ex-
clusion criteria included: birth weight >1,500 g, gestation
³37 weeks, presence of major congenital malformations
and incomplete medical records.
All the placentas in cases of preterm delivery were
sent for pathological examination. After a gross examina-
tion, samples of the free margin of fetal membranes, and
the umbilical cord and at least 2 samples of the full thick-
ness of placental tissue were taken for microscopic exam-
ination. Chorioamnionitis was diagnosed when an acute
inflammatory infiltrate consisting of neutrophils was
found in the amniotic membranes and chorion of the pla-
centa7,8. According to histopathological findings, the in-
fants included in the study were divided into two main
groups: one including pregnancies complicated by chorio-
amnionitis and the other representing the control group
(pregnancies without chorioamnionitis). According to the
gestational age, that was estimated by early ultrasono-
graphy or based on the last menstrual period, the infants
were divided into three groups: I – group of infants born
at £28 weeks of gestation, II – group of infants born from
29 to 32 weeks of gestation and III – group of infants
born at ³33 weeks of gestation.
All newborns included in the study had their blood
and gastric aspirate sampled for microbiological analysis
right after delivery using standard diagnostic culture
techniques. The criteria for EONS were positive microbi-
ological findings or clinical evidence of infection in the
first three days of life along with a positive sepsis screen
(raised level of C reactive protein, abnormal number of
white blood cells and raised ratio of immature to total
neutrophils)9. BPD was diagnosed in premature new-
borns that were treated with supplemental oxygen for at
least 28 days and still depended on it at/after 36 post-
menstrual weeks and that had characteristic radiogra-
phic findings of chronic lung disease.
Statistics
The statistical analysis was performed with SPSS ver-
sion 12.0 (SPSS, Inc, Chicago, IL) with c2-test. A p value
of<0.05 was considered significant.
Results
During the five year period 491 preterm newborns
with birth weight £1,500 grams were admitted to the
Neonatal Intensive Care Unit of the Departement of Ob-
stetrics and Gynecology of the Zagreb Clinical Hospital
Center; 395 of them were included in this study. An in-
flammation of fetal membranes was diagnosed in 184/
395 (47%) placentas. The group of infants with the patho-
logical diagnosis of chorioamnionitis and the control
group were compared for mortality and morbidity.
There were 132/395 (33%) infants in the gestational
age group I (gestation duration 28 weeks or less), 202/
395 (52%) infants were in the gestational age group II (29
to 32 weeks of gestation), and 61/395 (15%) infants were
in the gestational age group III (gestation of 33 weeks or
longer).
The differences between the number of infants with
chorioamnionitis at placental histology and the number
of control group infants for all three gestational age
groups are shown in Figure 1. A statistically significant
between-group difference regarding the presence of his-
tologic chorioamnionitis was found only among infants
whose gestational age at birth was 28 weeks or less
(c2=51.307, p<0.05).
The overall mortality rate was 17% (67/395) and cho-
rioamnionitis was diagnosed in 37 of 67 infants that died
(55%) (c2=2.421, p>0.05). However, in the gestational
age group I infants (28 weeks of gestation or less) with le-
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Fig. 1. Gestational weeks at birth and the number of preterm in-
fants in the histological chorioamnionitis group and the control
group; in the gestational age group 28 weeks and less chorio-
amnionitis was diagnosed significantly more often (c2=51.307,
p<0.05).
thal outcome, there were significantly more infants from
pregnancies complicated by chorioamnionitis than the
control group infants (30/54; 55%) (c2=7.645, p<0.01).
EONS was present in 100/395 (25%) infants included
in the study and in 66 (66%) of them an inflammation
was diagnosed at placental histology. EONS was found
statistically more often in infants with chorioamnionitis
than in the control group. (c2=22.396, p<0.01).
BPD developed in 25/395 (6%) premature infants in
the study, 12/25 (48%) of them with chorioamnionitis. As
the mortality rate was high many premature infants did
not survive long enough to develop BPD, so death was in-
cluded as an outcome. Analysing composite outcome of
BPD or death, there were 90/395 (23%) infants who de-
veloped BPD or died, and 48/90 (53%) were born from
pregnancies complicated by chorioamnionitis. We did not
find statistically significant difference between the group
with chorioamnionitis and the control group regarding
the incidence of BPD or death (c2=0.022, p>0.05; c2=
2.135, p>0.05).
Discussion
With the advances of neonatal care the survival rate
of very low and extremely low gestational age newborns
has greatly improved, so that nowadays 80% of preterm
neonates with birth weight of 500 to 1000 g survive, but
the rate of infants with disabilities is increasing as
well4,6. Chorioamnionitis is an important risk factor for
neonatal mortality and morbidity10. In this study, cho-
rioamnionitis was histopathologically confirmed in 47%
of placentas, the result that is in accordance to other sim-
ilar studies that showed chorioamnionitis in 33% to 50%
of placentas of prematurely born infants with very low
birth weight11–13. Similarly to other studies, our study
also showed that pregnancies complicated by acute cho-
rioamnionitis significantly more often result in the very
premature birth, at 28 or less weeks of gestation3,14,15.
In other studies the mortality rate in premature new-
borns ranged from 4% to 21%, while in this study it was
found to be 17%10,12,16. The reported effects of intra-
uterine infection on the mortality rate are controversial,
so that some authors found an association of intrauterine
infection with higher mortality rate, while others con-
cluded that the risk of lethal outcome was lower in the
presence of intrauterine infection13,17. We found statisti-
cally higher mortality rate in the group of infants with
chorioamnionitis in comparison with the control group
only in premature newborns with gestation of 28 weeks
or less. The mortality rate did not differ significantly be-
tween infants with chorioamnionitis and control group
infants in two other gestational age groups with longer
duration of gestation. We speculate that inflammatory
mediators produced during the maternal and fetal in-
flammatory responses contributed to the significantly
higher mortality of infants with chorioamnionitis, com-
bined with extremely low gestational age that is, itself,
associated with high mortality.
In most studies, the frequency of EONS ranged from
3% to 20%18–21. In our study the incidence of EONS was
found to be 25%, with a significant difference between
the group of infants with chorioamnionitis and the con-
trol group of infants. This result is similar to the results
of other authors13.
We found that 6% of premature infants included in
the study developed BPD. This percentage was lower
than expected 15% to 50%, as reported in other studies22.
Statistically significantly higher incidence of BPD or
death in the group of preterm infants with chorioamnio-
nitis was not found. Some authors found an association
between intrauterine infection and development of BPD,
while others did not11,22–24. Dexter et al. did not find a
corellation between development of BPD and intraute-
rine infection19. In their study of 241 preterm infants
Kent and Dahlstrom analysed the composite outcome of
BPD and/or lethal outcome from RDS in the first few
days of life, and showed the result of 33%, and no correla-
tion between chorioamnionitis and development of BPD.
The study found that the main predictor for the develop-
ment of BPD is low gestational age11. Van Marter et al.
found that premature newborns exposed to chorioamnio-
nitis have a lower risk for developing BPD in addition to
the mechanical ventilation shorter than 7 days. They
found that, in addition to chorioamnionitis, there is a
greater risk for developing BPD in the presence of me-
chanical ventilation longer than 7 days or postnatal in-
fection25. The results of Watterberg et al. show that pre-
term neonates born from pregnancies complicated by
chorioamnionitis have a lower incidence of the respira-
tory distress syndrome (RDS) but that the incidence of
BPD is higher23. They conclude that the prenatal inflam-
matory process improves the maturation of fetal lungs,
leading to a smaller incidence and milder clinical picture
of RDS. The presence of postnatal inflammation contrib-
utes to an increase in the changes in the lung tissue, pro-
moting the development of BPD23,26. Been et al. found
that the histological chorioamnionitis is associated with
the deteriorated response to exogenous surfactant in in-
fants with gestational age<32 weeks27. An overview of
literature shows that there is no consensus about the ef-
fects of chorioamnionitis on the fetal lung maturation
and the development of BPD. Jobe explains that BPD is a
complex lung development/injury/repair syndrome, which
is affected by chorioamnionitis in an inconsistent way be-
cause of different organisms, duration of exposure and
different fetal/maternal responses. BPD is also affected
by multiple postnatal modulators, such as ventilation
time, oxygen exposures, postnatal sepsis, patent ductus
arteriosus and nutrition28. A recent meta-analysis of 59
studies with 15295 patients included showed that chorio-
amnionitis is significantly associated with BPD, but it
cannot be definitively considered as a risk factor for
BPD29.
Conclusion
The study proves that premature neonates from preg-
nancies complicated by histological chorioamnionitis are
more often than not born with 28 or less weeks of gesta-
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tion. Histological chorioamnionitis in neonates with 28
or less weeks of gestation leads to a significantly higher
mortality than is the case with neonates with a longer
gestation period. A greater incidence of EONS was proven
in the group of infants with chorioamnionitis. Preterm
infants born from chorioamnionitis-complicated preg-
nancies did not show a greater incidence of BPD.
The histological evaluation of changes in the pla-
centa, fetal membranes and umbilical cord gives a valu-
able insight into important pathophysiological processes
during the prenatal period, which can have an important
impact on neonatal mortality and morbidity. Chorioam-
nionitis must not be regarded only as an isolated process
during the fetal period but should be observed in contin-
uum with postnatal insults. Early detection and treat-
ment of clinically silent chorioamnionitis could be a way
towards decreasing the rate of preterm deliveries and re-
ducing all the other negative consequences. A further
evaluation of the effects of chorioamnionitis on neonatal
mortality and morbidity is needed.
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UTJECAJ KORIOAMNIONITISA NA MORTALITET, RANU SEPSU I BRONHOPULMONALNU
DISPLAZIJU U NEDONO[^ADI PORODNE TE@INE £1,500 GRAMA
S A @ E T A K
Cilj ove retrospektivne studije je istra`iti utjecaj korioamnionitisa na mortalitet, ranu novoro|ena~ku sepsu (EONS)
i bronhopulmonarnu displaziju (BPD) u nedono{~adi porodne te`ine £1,500 g. U studiju je uklju~eno 395 nedono{~adi
ro|enih u Klini~kom bolni~kom centru Zagreb, u periodu od sije~nja 2001. do prosinca 2005. Ispitanici su podijeljeni u 2
skupine prema nalazu patohistolo{kog pregleda posteljice, plodovih ovoja i pupkovine: u skupinu ~ija je trudno}a kom-
plicirana korioamnionitisom i kontrolnu skupinu bez korioamnionitisa. Korioamnionitis je potvr|en u 184 (47%) ispi-
tanih posteljica. Nedono{~ad je podijeljena prema gestacijskoj dobi: bilo je 132 (33%) gestacije £28 tjedana, 202 (52%)
gestacije 29 do 32 tjedna i 61 (15%) gestacije ³33tjedna. U skupini nedono{~adi s gestacijom £28 tjedana bilo je 91/132
(69%) nedono{~e ro|eno iz trudno}e komplicirane korioamnionitisom (c2=51,307, p<0,05). Smrtni ishod je uslijedio u
67 (17%) ispitanika, a 37/67 (55%) je bilo u skupini s korioamnionitisom (c2=2,421, p>0,05). U skupini nedono{~adi ~ija
je gestacija £28 tjedana umrlo je 54/132 (41%) ispitanika, a 30/54 (55%) je ro|eno iz trudno}e komplicirane korioamnio-
nitisom. Utvr|en je statisti~ki zna~ajno vi{i mortalitet u skupini nedono{~adi gestacije £28 tjedana koja je u trudno}i
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bila izlo`ena korioamnionitisu (c2=7,645, p<0,01). EONS je utvr|en u 100 (25%) ispitanika, a 66/100 (66%) je bilo iz
skupine ~ija trudno}a je optere}ena korioamnionitisom, {to je pokazalo statisti~ki zna~ajnu razliku u odnosu na kon-
trolnu skupinu (c2=22,396, p<0.01). BPD je razvijen u 25 (6%) ispitanika, a 12/25 (48%) je pripadalo skupini koja je u
trudno}i izlo`ena korioamnionitisu (c2=0,022, p>0,05). Trudno}e komplicirane korioamnionitisom statisti~ki zna~aj-
no ~e{}e zavr{avaju porodom £28 tjedana gestacije. Utvr|en je statisti~ki zna~ajno ve}i mortalitet u nedono{~adi ges-
tacije £28 tjedana ukoliko su bila izlo`ena korioamnionitisu. U skupini nedono{~adi ro|enih iz trudno}e s korioam-
nionitisom je statisti~ki zna~ajno ~e{}a pojava EONS-a. Nedono{~ad ~ije su majke u trudno}i imale korioamnionitis
nema statisti~ki zna~ajno ~e{}u pojavnost BPD-a.
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